Filter by: patients
Home > Community Treatment Reports and Side Effects > Botulinum Toxin Type A Treatment Report
What is Botulinum Toxin Type A?

Botulinum Toxin Type A is a neuromuscular blocker age. It is used to treat various types of dystonia (neurological movement disorders); for blepharospasm and strabismus; for primary axillary hyperhidrosis (excessive perspiration); and it is also used for cosmetic purposes.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Stiffness/Spasticity 29 11 Efficacy_major Efficacy_moderate Efficacy_slight
Other 23 6 Efficacy_major Efficacy_moderate Efficacy_slight
Excess saliva 19 7 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Bladder problems 11 5 Efficacy_major
Migraine headaches 10 1 Efficacy_cant_tell
Migraine 7 3 Efficacy_moderate Efficacy_slight Efficacy_none

See all 122 patients currently taking Botulinum Toxin Type A

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 3
Moderate
 11
Mild
 5
None
 42

Commonly reported side effects, conditions, and hospitalizations associated with Botulinum Toxin Type A

Injection site pain 4
Muscles burning 2
Muscle aches 2
Muscle weakness 2
Weakness in arms 2
Numbness 2
See all 33 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Botulinum Toxin Type A. See all 51 dosages ►

  100units as needed IU as needed as needed 2 100units as needed 1 other every 3 months 100 units yearly 100 units every 3 months 200 units every 3 months 100 units monthly 100 units one time
  17 Number of Patients: 17 5 Number of Patients: 5 4 Number of Patients: 4 5 Number of Patients: 5 3 Number of Patients: 3 4 Number of Patients: 4 14 Number of Patients: 14 12 Number of Patients: 12 5 Number of Patients: 5 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Botulinum Toxin Type A (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 23   Did not seem to work: 38%
Course of treatment ended 16   Course of treatment ended: 27%
Other 11   Other: 18%
Not indicated 9   Not indicated: 15%
Expense 8   Expense: 13%
Side effects too severe 7   Side effects too severe: 12%
Doctor's advice 3   Doctor's advice: 5%
Personal research 3   Personal research: 5%

See all 59 patients who’ve stopped taking Botulinum Toxin Type A

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Botulinum Toxin Type A

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Botulinum Toxin Type A

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Botulinum Toxin Type A

Always
 41 67%
Usually
 7 11%
Sometimes
 7 11%
Never
 6 10%

Burden

Difficulty being on treatment

Burden of Botulinum Toxin Type A

Very
 8 13%
Somewhat
 8 13%
A little
 16 26%
Not at all
 29 48%

Cost

Paid out of pocket

Cost of Botulinum Toxin Type A

$200+
 10 26%
$100-199
 7 18%
$50-99
 3 8%
$25-49
 0 0%
< $25
 18 47%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.